<DOC>
	<DOCNO>NCT03028077</DOCNO>
	<brief_summary>This study conduct investigate effect daily supplementation GS-3K8 GINst15 acute respiratory illness ( ARI ) healthy subject .</brief_summary>
	<brief_title>Effects GS-3K8 GINst15 Acute Respiratory Illness</brief_title>
	<detailed_description>This study 8 week , randomize , double-blind , placebo-controlled trial . Forty five subject randomly divide GS-3K8 ( Ultrafiltered red ginseng extract ) GINst15 ( Hydrolyzed ginseng extract ) placebo group . The primary clinical outcome measure incidence ARI . The secondary clinical outcome measure development duration ARI symptom .</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Age 3965 year healthy adult Subjects vaccinate influenza previous 6 month Subjects symptoms upper respiratory tract infection Subjects acute/chronic disease History alcohol substance abuse History disease could interfere test product impede absorption Subjects take medication immune upper respiratory tract infection relate drug functional food Abnormal liver kidney function test Pregnant lactate woman heavy smoker Being judge responsible physician local study center unfit participate study</criteria>
	<gender>All</gender>
	<minimum_age>39 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ultrafiltered red ginseng</keyword>
	<keyword>hydrolyze ginseng</keyword>
	<keyword>acute respiratory illness</keyword>
	<keyword>clinical trial</keyword>
</DOC>